High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote v 9V 2 T-Cell Chemotaxis and Cytotoxicity in Vivo

Cancer Research - United States
doi 10.1158/0008-5472.can-10-3862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Differentiation, Phenotype, and Function of Interleukin-17-Producing Human v 9V 2 T Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Lack of CD27-CD45RA-V 9V 2+ T Cell Effectors in Immunocompromised Hosts and During Active Pulmonary Tuberculosis

Journal of Immunology
AllergyImmunology
2002English

Editorial: V 9V 2 T Cells: Triple Costimulation Goes the Distance

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2016English

Triple Costimulation via CD80, 4-1bb, and CD83 Ligand Elicits the Long-Term Growth of v 9V 2 T Cells in Low Levels of IL-2

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2015English

Sorafenib Combined With HER-2 Targeted Vaccination Can Promote Effective T Cell Immunity in Vivo

International Immunopharmacology
AllergyImmunologyPharmacology
2017English

Complex Interplay of Activating and Inhibitory Signals Received by v 9V 2 T Cells Revealed by Target Cell 2-Microglobulin Knockdown

Journal of Immunology
AllergyImmunology
2006English

Triptolide-Induced in Vitro and in Vivo Cytotoxicity in Human Breast Cancer Stem Cells and Primary Breast Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2014English

Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-Dm1 in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

T-Cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy